237 filings
Page 2 of 12
8-K
1ktkcj1
1 Nov 23
Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
4:07pm
8-K
bki94lz
1 Aug 23
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
4:10pm
8-K
hagbw4s
7 Jul 23
Departure of Directors or Certain Officers
4:37pm
8-K
oq7d7mvbd q3
5 Jun 23
Departure of Directors or Certain Officers
4:10pm
8-K
miu5836o5d69lja1kl
30 May 23
Departure of Directors or Certain Officers
5:00pm
SD
t43roo8k83rys5i6
23 May 23
Conflict minerals disclosure
5:04pm
8-K
97e5 x8s7kh
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
S-8
0ej vmalf
21 Apr 23
Registration of securities for employees
4:36pm
8-K
164oi9
19 Apr 23
Results of Operations and Financial Condition
5:07pm
DEFA14A
zfpr6p88js uuq
12 Apr 23
Additional proxy soliciting materials
4:55pm
S-8
zulfxy ea61
21 Feb 23
Registration of securities for employees
7:15am
8-K
sx63zm
16 Feb 23
Nevro Announces Fourth Quarter and Full-Year 2022 Financial Results
4:11pm
8-K
2gig oabc
9 Jan 23
Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2022 Revenue and Provides Full-Year 2023 Revenue Guidance
6:05am
8-K
mu4pf2
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
now91n ojg6k
9 Sep 22
Departure of Directors or Certain Officers
4:49pm